Advanced search
Publication Cover
Autoimmunity Volume 37, 2004 - Issue 6-7
Submit an article Journal homepage
67
Views
35
CrossRef citations to date
0
Altmetric
Original Article

Anti-cyclic Citrullinated Peptide Antibodies are Highly Associated with Severe Bone Lesions in Rheumatoid Arthritis Anti-CCP and Bone Damage in RA

Susanna Maddali Bongi Department of Medical and Surgical Care, Rheumatology Unit, University of Florence, Florence, Italy
,
Roberto Manetti Center of Research, Transfer, High Education, MCIDNENT, University of Florence, Viale Morgagni 85, 50134, Florence, ItalyCorrespondence[email protected]
,
Daniela Melchiorre Department of Medical and Surgical Care, Rheumatology Unit, University of Florence, Florence, Italy
,
Stefano Turchini Center of Research, Transfer, High Education, MCIDNENT, University of Florence, Viale Morgagni 85, 50134, Florence, Italy
,
Piero Boccaccini Center of Research, Transfer, High Education, MCIDNENT, University of Florence, Viale Morgagni 85, 50134, Florence, Italy
,
Lorenzo Vanni Department of Medical and Surgical Care, Rheumatology Unit, University of Florence, Florence, Italy
&
Enrico Maggi Center of Research, Transfer, High Education, MCIDNENT, University of Florence, Viale Morgagni 85, 50134, Florence, Italy
 show all
Pages 495-501 | Received 14 Jun 2004, Accepted 14 Sep 2004, Published online: 07 Jul 2009

References

  • Kvien, T.K. (2004) "Epidemiology and burden of illness of rheumatoid arthritis", Phannacoeconomics 22(2 Suppl.), 1–12.
  • Wilske, KR. and Healey, L.A. (1989) "Remodeling the pyramid concept whose time has come", J. Rheumatol. 16, 565–567.
  • Fries, J.F. (1990) "Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy", J. Rheumatol. 1, 12–15.
  • Emery, P. (1994) "The optimal management of early rheumatoid disease the key to preventing disability", Br J. Rheumatol. 33, 765–768.
  • van der Heide, A., Jacobs, J.W., Bijlsma, J.W., Heurkens, A.H., van Booma-Frankfort, C., van der Veen, M.J., Haanen, H.C., Hoffman, D.M., van Albada-Kuipers, G.A., ter Borg, EL, Brus, H.L., Dinant, H.J., Kruize, A.A. and Schenk, Y. (1996) "The effectivenes of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial", Ann. Intern. Med. 124, 699–707.
  • Hasfeld, W., Steiner, G., Graninger, W., Witzmann, G., Schweitzer, H. and Smolen, J.S. (1993) "Autoantibody to the nuclear antigen RA33; a marker for early rheumatoid arthritis", Br J. Rheumatol. 32, 199–203.
  • Deprés, N., Boire, G., Lopez-Longo, F.J. and Ménard, H.A. (1994) "The SA system: a novel antigen-antibody system specific for rheumatoid arthritis", J. Rheumatol. 21, 1027–1033.
  • Blass, S., Haferkamp, C., Specker, C., Schwochau, M., Schneider,M. and Schneider, E.M. (1997) "Rheumatoid arthritis: autoreactive T cells recognising a novel 68 k autoantigen", Ann. Rheum. Dis. 56, 317–322.
  • Lackner, K.J., Schlosser, U., Lang, B. and Schmitz, G. (1998) "Autoantibodies aganinst human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patients sera", Br. J. Rheumatol. 37, 1164–1171.
  • Nienhuis, R.L.F. and Mandema, E.A. (1964) "A new serum factor in patient with rheumatoid arthritis: the antiperinuclear factor", Ann. Rheum. Dis. 23, 302–305.
  • Hoet, R.M. and van Venrooij, W.J. (1992) "The antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis", In: Smolen, J.S., Kalden, J.R. and Maini, R.N., eds, Rheumatoid Arthritis (Springer Verlag, Berlin), pp 299–318.
  • Van Schaardenburg, D., Lagaay, AM., Otten, HG. and Breedveld, F.C. (1993) "The relation between class-specific serum rheumatoid factors and age in general population", Br J. Rheumatol. 32,546–549.
  • Goldbach-Mansky, R., Lee, J., McCoy, A., Hoxworth, J., Yarboro,C., Smolen, IS., Steiner, G., Rosen, A., Zhang, C., Ménard, RA., Thou, Z.J., Palosuo, T., van Venrooij, W.J., Wilder, R.L., Klippel, J.H., Schumacher, RR., Jr. and El-Gabalawy, H.S. (2000) "Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset", Arthritis Res. 2, 236–243.
  • Schellekens, GA., de Jong, B.A.W., van den Hoogen, F.H.J., van de Putte, L.B.A. and van Verooij, W.J. (1998) "Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies", J. Clin. Investig. 101, 273–281.
  • Mediwake, R., Isemberg, D.A., Schellekens, G.A. and van Venrooij, W.J. (2001) "Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis", Ann. Rheum. Dis. 60, 67–68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.